Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1956 3
1957 3
1958 3
1959 7
1960 2
1961 1
1962 1
1964 3
1965 4
1966 1
1967 3
1968 1
1969 7
1970 5
1971 6
1972 8
1973 1
1974 8
1975 3
1976 5
1977 9
1978 4
1979 11
1980 10
1981 18
1982 13
1983 11
1984 16
1985 14
1986 44
1987 29
1988 31
1989 18
1990 19
1991 25
1992 28
1993 30
1994 33
1995 22
1996 36
1997 38
1998 33
1999 33
2000 39
2001 53
2002 39
2003 40
2004 42
2005 46
2006 39
2007 66
2008 51
2009 48
2010 65
2011 59
2012 82
2013 74
2014 82
2015 64
2016 49
2017 67
2018 86
2019 98
2020 87
2021 60
Text availability
Article attribute
Article type
Publication date

Search Results

1,780 results
Results by year
Filters applied: . Clear all
Page 1
Gut microbiota and major depressive disorder: A systematic review and meta-analysis.
Sanada K, Nakajima S, Kurokawa S, Barcel├│-Soler A, Ikuse D, Hirata A, Yoshizawa A, Tomizawa Y, Salas-Valero M, Noda Y, Mimura M, Iwanami A, Kishimoto T. Sanada K, et al. Among authors: noda y. J Affect Disord. 2020 Apr 1;266:1-13. doi: 10.1016/j.jad.2020.01.102. Epub 2020 Jan 23. J Affect Disord. 2020. PMID: 32056863 Review.
Effectiveness of theta burst versus high-frequency repetitive transcranial magnetic stimulation in patients with depression (THREE-D): a randomised non-inferiority trial.
Blumberger DM, Vila-Rodriguez F, Thorpe KE, Feffer K, Noda Y, Giacobbe P, Knyahnytska Y, Kennedy SH, Lam RW, Daskalakis ZJ, Downar J. Blumberger DM, et al. Among authors: noda y. Lancet. 2018 Apr 28;391(10131):1683-1692. doi: 10.1016/S0140-6736(18)30295-2. Epub 2018 Apr 26. Lancet. 2018. PMID: 29726344 Clinical Trial.
Kynurenine pathway in depression: A systematic review and meta-analysis.
Ogyu K, Kubo K, Noda Y, Iwata Y, Tsugawa S, Omura Y, Wada M, Tarumi R, Plitman E, Moriguchi S, Miyazaki T, Uchida H, Graff-Guerrero A, Mimura M, Nakajima S. Ogyu K, et al. Among authors: noda y. Neurosci Biobehav Rev. 2018 Jul;90:16-25. doi: 10.1016/j.neubiorev.2018.03.023. Epub 2018 Mar 30. Neurosci Biobehav Rev. 2018. PMID: 29608993
Efficacy, tolerability, and cognitive effects of deep transcranial magnetic stimulation for late-life depression: a prospective randomized controlled trial.
Kaster TS, Daskalakis ZJ, Noda Y, Knyahnytska Y, Downar J, Rajji TK, Levkovitz Y, Zangen A, Butters MA, Mulsant BH, Blumberger DM. Kaster TS, et al. Among authors: noda y. Neuropsychopharmacology. 2018 Oct;43(11):2231-2238. doi: 10.1038/s41386-018-0121-x. Epub 2018 Jun 18. Neuropsychopharmacology. 2018. PMID: 29946106 Free PMC article. Clinical Trial.
Neurophysiological biomarkers using transcranial magnetic stimulation in Alzheimer's disease and mild cognitive impairment: A systematic review and meta-analysis.
Mimura Y, Nishida H, Nakajima S, Tsugawa S, Morita S, Yoshida K, Tarumi R, Ogyu K, Wada M, Kurose S, Miyazaki T, Blumberger DM, Daskalakis ZJ, Chen R, Mimura M, Noda Y. Mimura Y, et al. Among authors: noda y. Neurosci Biobehav Rev. 2021 Feb;121:47-59. doi: 10.1016/j.neubiorev.2020.12.003. Epub 2020 Dec 8. Neurosci Biobehav Rev. 2021. PMID: 33307047 Review.
[ERCP].
Koshita S, Kobayashi G, Noda Y, Ito K, Kanno Y. Koshita S, et al. Among authors: noda y. Nihon Rinsho. 2015 Mar;73 Suppl 3:67-73. Nihon Rinsho. 2015. PMID: 25856987 Japanese. No abstract available.
Glutamatergic neurometabolite levels in major depressive disorder: a systematic review and meta-analysis of proton magnetic resonance spectroscopy studies.
Moriguchi S, Takamiya A, Noda Y, Horita N, Wada M, Tsugawa S, Plitman E, Sano Y, Tarumi R, ElSalhy M, Katayama N, Ogyu K, Miyazaki T, Kishimoto T, Graff-Guerrero A, Meyer JH, Blumberger DM, Daskalakis ZJ, Mimura M, Nakajima S. Moriguchi S, et al. Among authors: noda y. Mol Psychiatry. 2019 Jul;24(7):952-964. doi: 10.1038/s41380-018-0252-9. Epub 2018 Oct 12. Mol Psychiatry. 2019. PMID: 30315224 Free PMC article.
The Levels of Interferon-gamma Release as a Biomarker for Non-small-cell Lung Cancer Patients Receiving Immune Checkpoint Inhibitors.
Hirashima T, Kanai T, Suzuki H, Yoshida H, Matsushita A, Kawasumi H, Samejima Y, Noda Y, Nasu S, Tanaka A, Morishita N, Hashimoto S, Kawahara K, Tamura Y, Okamoto N, Tanaka T. Hirashima T, et al. Among authors: noda y. Anticancer Res. 2019 Nov;39(11):6231-6240. doi: 10.21873/anticanres.13832. Anticancer Res. 2019. PMID: 31704852
1,780 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page